← Leaderboards
Katherine L Narr
University Of California Los Angeles
$12,999,877
Attributed
$24,335,474
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,335,474 · 13
By mechanism
R01$9,706,543 · 4
U01$5,525,791 · 1
R33$3,167,622 · 1
RF1$2,255,123 · 1
R61$2,157,582 · 1
K24$889,490 · 1
Top collaborators
- Randall Espinoza12 shared
- Helen Lavretsky6 shared
- Danny Jiong Jiong Wang6 shared
- Janine Diane Bijsterbosch3 shared
- Yvette I Sheline3 shared
- Susan Whitfield-Gabrieli3 shared
- Leanne Williams3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Helen Lavretsky$17,053,369
- Agatha Lenartowicz$5,164,174
- Jamie Feusner$10,846,177
- Randall Espinoza$4,434,685
- Sandra K Loo$8,489,078
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainImageMagnetic Resonance ImagingBaseAntidepressive AgentsResponseMajor Depressive DisorderMental DepressionFunctional Magnetic Resonance ImagingBiological MarkersEffective TherapyLinkTreatment ResponseDesignElectroconvulsive TherapyStructureFundingRelating To Nervous SystemCognitivePeripheralProtocols DocumentationLeadPhenotypePharmacotherapy
Grant awards (40)
HCP-2.0: Ascertaining Network Mechanisms and Analytics of Emotional Dysfunction (HARMONY)$2,255,123
RF1 · FY2025 · MH
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)$571,781
R01 · FY2025 · MH · contact PI
HCP-2.0: Ascertaining Network Mechanisms and Analytics of Emotional Dysfunction (HARMONY)$778,117
R01 · FY2024 · MH
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)$571,781
R01 · FY2024 · MH · contact PI
HCP-2.0: Ascertaining Network Mechanisms and Analytics of Emotional Dysfunction (HARMONY)$846,403
R01 · FY2023 · MH
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)$571,781
R01 · FY2023 · MH · contact PI
Imaging-guided tDCS therapy in major depression$1,041,814
R33 · FY2022 · MH · contact PI
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)$585,901
R01 · FY2022 · MH · contact PI
Imaging-guided tDCS therapy in major depression$1,062,157
R33 · FY2021 · MH · contact PI
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression$206,942
R01 · FY2021 · MH
Imaging-guided tDCS therapy in major depression$1,063,651
R33 · FY2020 · MH · contact PI
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression$277,354
R01 · FY2020 · MH
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,406,351
U01 · FY2019 · MH · contact PI
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression$430,103
R01 · FY2019 · MH
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression$106,699
R01 · FY2019 · MH
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,363,539
U01 · FY2018 · MH · contact PI
Imaging-guided tDCS therapy in major depression$1,074,312
R61 · FY2018 · MH · contact PI
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression$372,305
R01 · FY2018 · MH
Biomarkers of fast acting therapies in major depression$177,898
K24 · FY2018 · MH · contact PI
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,363,539
U01 · FY2017 · MH · contact PI
Imaging-guided tDCS therapy in major depression$1,083,270
R61 · FY2017 · MH · contact PI
4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depression$359,548
R01 · FY2017 · MH
Biomarkers of fast acting therapies in major depression$177,898
K24 · FY2017 · MH · contact PI
Perturbation of the treatment resistant depression connectome by fast-acting therapies$1,392,362
U01 · FY2016 · MH · contact PI
Biomarkers of fast acting therapies in major depression$177,898
K24 · FY2016 · MH · contact PI
Imaging biomarkers of ECT response in major depressive disorder$918,328
R01 · FY2015 · MH · contact PI
Biomarkers of fast acting therapies in major depression$177,898
K24 · FY2015 · MH · contact PI
Imaging biomarkers of ECT response in major depressive disorder$974,291
R01 · FY2014 · MH · contact PI
Biomarkers of fast acting therapies in major depression$177,898
K24 · FY2014 · MH · contact PI
Imaging biomarkers of ECT response in major depressive disorder$552,905
R01 · FY2013 · MH · contact PI
Imaging biomarkers of ECT response in major depressive disorder$398,353
R01 · FY2013 · MH · contact PI
Imaging biomarkers of ECT response in major depressive disorder$575,942
R01 · FY2012 · MH · contact PI
Imaging biomarkers of ECT response in major depressive disorder$608,009
R01 · FY2011 · MH · contact PI
MAPPING THE MTL MEMORY SYSTEM IN SCHIZOPHRENIA$10,135
P41 · FY2011 · RR · contact PI
MAPPING THE MTL MEMORY SYSTEM IN SCHIZOPHRENIA$9,118
P41 · FY2010 · RR · contact PI
Mapping the MTL Memory System in Schizophrenia$157,353
K01 · FY2009 · MH · contact PI
MAPPING THE MTL MEMORY SYSTEM IN SCHIZOPHRENIA$3,406
P41 · FY2009 · RR · contact PI
Mapping the MTL Memory System in Schizophrenia$153,409
K01 · FY2008 · MH · contact PI
Mapping the MTL Memory System in Schizophrenia$149,580
K01 · FY2007 · MH · contact PI
Mapping the MTL Memory System in Schizophrenia$150,322
K01 · FY2006 · MH · contact PI